Survey on young lung cancer and its potential causes
This is a 100% Virtual (Remote) Study (Survey, and Voluntary Blood Donation) to Explore Potential Environmental, Lifestyle and Genetic Factors That May be Associated With Driver Mutations of Young Lung Cancer in the USA.
This study is trying to learn more about the causes of lung cancer in young people by asking those diagnosed with it before age 50 to share their experiences through an online survey.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Addario Lung Cancer Medical Institute Academic / other |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Trial ID | NCT04640259 on ClinicalTrials.gov |
What this trial studies
This observational study is a fully virtual survey aimed at exploring the environmental, lifestyle, and genetic factors associated with driver mutations in young lung cancer patients in the U.S. Participants will be required to complete an online survey to provide information about their experiences and backgrounds. The study focuses on individuals diagnosed with non-small cell lung cancer (NSCLC) before the age of 50, gathering data to better understand the epidemiology of this condition.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and over who have been diagnosed with NSCLC at or before the age of 50 and have undergone genomic testing.
Not a fit: Patients diagnosed with NSCLC at age 50 or older or those without documentation of mutation testing may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the causes of young lung cancer, potentially leading to improved prevention and treatment strategies.
How similar studies have performed: While studies on lung cancer exist, this specific focus on young patients and their unique risk factors is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female aged 18 years and over; or the age of majority for their residential state at the time of enrollment 2. Documentation of primary NSCLC, any stage 3. Less than 50 years of age at the time of NSCLC diagnosis 4. Documentation of testing by a CLIA certified lab for genomic drivers of lung cancer 5. Willingness to undergo all study procedure 6. Provision of written informed consent Exclusion Criteria: 1. Male or female aged less than 18 years; or less than the age of majority for their residential state 2. Greater than or equal to 50 years of age at the time of NSCLC diagnosis 3. No documentation of mutation testing 4. Unwilling to undergo all study procedures 5. Unable or unwilling to provide consent
Where this trial is running
Los Angeles, California and 1 other locations
- USC Keck School of Medicine — Los Angeles, California, United States (Recruiting)
- Addario Lung Cancer Medical Institute — San Carlos, California, United States (Recruiting)
Study contacts
- Principal investigator: Jorge Nieva, MD — University of Southern California
- Study coordinator: Richard Erwin
- Email: rerwin@alcmi.net
- Phone: 888-443-6952
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.